Total (n=159) Patients with KMP (n=64) Patients without KMP (n=95) p-value
Age at diagnosis (days), median [IQR] 154.0 [32.0, 510.5] 49.5 [10.8, 150.8] 293.0 [96.0, 794.0] <0.001
Age at treatment initiation (days), median [IQR] 159.5 [34.5, 539.8] 48.0 [18.0, 156.0] 300.00[125.0, 1016.0] <0.001
Female Sex, n (%) 61 (38.4%) 22 (34.4%) 39 (41.1%) 0.4
Diagnosis confirmed by biopsy, n (%) 133 (83.7%) 46 (71.9%) 87 (91.6%) 0.002
Tumor Location, n (%) Truncal Non-truncal Other 46 (28.9%) 94 (59.1%) 19 (12.0%) 26 (40.6%) 32 (50.0%) 6 (9.4%) 20 (21.1%) 62 (65.3%) 13 (13.7%)
0.029
Tumor Size, n (%) < 5cm ≥ 5cm Unmeasured/unknown 50 (31.5%) 95 (59.8%) 14 (8.8%) 7 (10.9%) 53 (82.8%) 4 (6.3%) 43 (45.3%) 42 (44.2%) 10 (10.5%)
<0.001
Tumor Extent, n (%) Localized/well-circumscribed or superficial (<3cm) Localized but not well-circumscribed, infiltrative (>3cm) Extensive across 1 body area Extensive, involving more than 1 body area Multifocal Other 21 (13.2%) 66 (41.5%) 40 (25.2%) 28 (17.6%) 2 (1.3%) 2 (1.3%) 0 (0%) 23 (35.9%) 19 (29.7%) 20 (31.3%) 0 (0%) 2 (3.1%) 21 (22.1%) 43 (45.3%) 21 (22.1%) 8 (8.4%) 2 (2.1%) 0 (0%)
<0.001
Presence of Coagulopathy at Diagnosis, n (%) 65 (40.9%) 51 (79.7%) 14 (14.7%) <0.001
≥ 1 Hospitalizations, n (%) 45 (28.3%) 27 (42.2%) 18 (19.0%) <0.001
Hospital Length of Stay (days), median [IQR] 2.0 [0.0, 11.0] 13.5 [5.0, 30.5] 0.0 [0.0, 2.0] <0.001
Length of ICU Stay (days), median [IQR] 0.0 [0.0, 3.0] 4.0 [0.0, 16.0] 0.0 [0.0, 0.0] <0.001
Deceased, n (%) 2 (1.3%) 2 (3.1%) 0 (0%) 0.2